SOPHIA Archives - Medical Conferences

Margetuximab does not improve pCR rate in HER2-positive early breast cancer

Presented By

Dr Adrienne Waks, Dana-Farber Cancer Institute, USA

Trial

Phase 2, MARGOT/TBCRC052

Conference

SABCS 2024

Type

Peer-reviewed article

23 January 2025 16:37

Presented By

Dr Shanu Modi , Memorial Sloan Kettering Cancer Center

Trial

DESTINY-Breast01

Journal

Physician's Weekly

Conference

SABCS 2020

13 April 2021 18:50

Trial

Phase 3, SOPHIA

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 12:45